Nicole Galvão-Coelho
As a Member, you’re not just making a donation — you’re joining a community that is at the forefront of advancing research, changing policy, and evolving education around psychedelics. Join us in shaping a future where these life-changing tools are available to those who need them most.
Ayahuasca, a psychoactive tea from Amazonian plants, shows promise in treating depression and grief. Urban ritual use has grown globally, including in the U.S., for addressing anxiety and depression.
Saleena Subaiya
Psychedelic-assisted therapies for adolescents are discussed, including the use of ketamine for treatment-resistant depression and the need for further studies and careful consideration of risks. Traditional use of plant medicines
Corine de Boer, Rebecca Kronman, Glauber Assis
Ayahuasca's potential for treating mental disorders is explored through a study at Takiwasi Center, a Peruvian facility offering an ayahuasca-assisted addiction program. The study evaluates outcomes up to 24 months
Olivia Marcus
Studies since 2005 show ayahuasca impacts memory, vision, introspection in the brain. Changes in hippocampus, visual cortex, frontopolar regions, default mode network observed during acute effects.
Robin Carhart-Harris, Head of Centre for Psychedelic Research at Imperial College London, conducted pioneering clinical studies with psilocybin and other psychedelic drugs for over 40 years. He collaborates with Professor
Entheogens are being used in traditional Indigenous medicine practices for therapeutic purposes. Indigenous initiatives are creating intercultural clinics to offer entheogen-assisted treatments for substance use disorders and mental health challenges.
Anja Loizaga-Velder
Roland Griffiths, Ph.D., from Johns Hopkins University, leads research on psilocybin's effects, including therapeutic studies for psychological distress, depression, addiction, and brain imaging for neural mechanisms.
Roland Griffiths
Dennis J. McKenna, Ph.D., a prominent ethnopharmacologist, co-founded the Heffter Research Institute and played a pivotal role in the Hoasca Project. He also taught Ethnopharmacology at the University of Minnesota.
Dennis J McKenna
Dr. Fadiman shares insights from personal psychedelic experiences and interactions with key pioneers, highlighting how psychedelics influence his Integrative Medicine philosophy and potential for global impact.
Andrew Weil
© 1986 – 2025 Multidisciplinary Association for Psychedelic Studies. All Rights Reserved.
3141 Stevens Creek Blvd #40563, San Jose, CA 95117.
Mailing: MAPS P.O. Box 103004 Pasadena, CA 91189-3004.